NCT06476587

Brief Summary

The goal of this exploratory study is to gain a better understanding of the symptomatology of idiopathic bilateral vestibulopathy (IBV) by characterising as precisely as possible the type and intensity of each patient's peripheral vestibular deficit, and to investigate the link between this symptomatology and some functions influenced by the vestibular system (i.e. cognitive, emotional, vegetative functions).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 5, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 26, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

1.2 years

First QC Date

May 22, 2024

Last Update Submit

July 22, 2025

Conditions

Outcome Measures

Primary Outcomes (11)

  • Center of pressure (CoP) path length

    Stabilometric data: Total length travelled by the CoP (in mm)

    Posturography is assessed once, during about 30 minutes.

  • Center of pressure (CoP) path amplitude

    Stabilometric data: Maximal distance over two points of the stabilogram (in mm)

    Posturography is assessed once, during about 30 minutes.

  • Center of pressure (CoP) surface area

    Stabilometric data: surface travelled by the CoP (in mm²)

    Posturography is assessed once, during about 30 minutes.

  • Ocular torsion

    During eccentric axis rotation: measure of the torsion of the eyes (in degree)

    Unilateral utricular otolith function is assessed once, during about 30 minutes

  • Duration estimate

    During the time perception task, subjects are asked to estimate several durations (in seconds).

    Time perception task is completed once, during about 30 minutes.

  • Duration production

    During the time perception task, subjects are asked to produce several durations (in seconds).

    Time perception task is completed once, during about 30 minutes.

  • Number of correct tandem steps

    During tandem stance and walk, subjects are asked to stand upright in a heel-to-toe fashion with their arms crossed on their chest and walk.

    Assessment of postural stability and active motion perception is completed once, during about 30 minutes

  • Deviation distance (Fukuda stepping test)

    During the Fukuda stepping test, subjects are asked to take 50 steps on the spot, on a mat, with their eyes closed and their arms outstretched in front of them. Deviation distance is measured in cm.

    Assessment of postural stability and active motion perception is completed once, during about 30 minutes

  • Deviation angle (Fukuda stepping test)

    During the Fukuda stepping test, subjects are asked to take 50 steps on the spot, on a mat, with their eyes closed and their arms outstretched in front of them. Deviation angle is measured in degrees.

    Assessment of postural stability and active motion perception is completed once, during about 30 minutes

  • Hippocampal volume

    Images of hippocampus are acquired by MRI

    MRI exam is completed once, during about 1 hour

  • Brain activation during functional tasks

    Images of the brain when participants are performing cognitive tasks (mental rotation task, prediction task) are acquired by functional magnetic resonance imaging (fMRI)

    MRI exam is completed once, during about 1 hour

Secondary Outcomes (14)

  • Center of pressure (CoP) standard deviation - Anteroposterior

    Posturography is assessed once, during about 30 minutes.

  • Center of pressure (CoP) standard deviation - Mediolateral

    Posturography is assessed once, during about 30 minutes.

  • Duration of the word reading in the congruent condition

    Cognitive functions are assessed once, during about 30 minutes

  • Duration of the colour naming

    Cognitive functions are assessed once, during about 30 minutes

  • Duration of the word reading in the incongruent condition

    Cognitive functions are assessed once, during about 30 minutes

  • +9 more secondary outcomes

Study Arms (2)

IBV patients

Persons with bilateral vestibulopathy

Other: Assessment of postural stability and active motion perceptionOther: Cognitive testsOther: Eccentric axis rotationOther: OsteodensitometryOther: PosturographyOther: Vestibulo-sympathetic regulation testOther: Sleep quality assessmentOther: Representation of space and time assessmentOther: Influence of vestibular information on the bodily self-consciousnessOther: 3 Tesla MRI

Controls

Healthy volunteers matched with patients with respect to their age, sex and level of education

Other: Assessment of postural stability and active motion perceptionOther: Eccentric axis rotationOther: PosturographyOther: Representation of space and time assessmentOther: 3 Tesla MRI

Interventions

This assessment, designed to evaluate the impact of the vestibular deficit on everyday tasks, will include questionnaires and standardised clinical tests. The questionnaires are the Fall Efficacy Scale; the Dizziness Handicap Inventory; the Oscillopsia Severity Questionnaire; the Hospital Anxiety and Depression Scale; the Hamilton Anxiety Scale; the Global Physical Activity Questionnaire; the Motion Sickness Susceptibility Questionnaire part B; and the Cambridge Depersonalization Scale. In addition, three standardised clinical tests will be carried out: Five Times Sit to Stand Test; Tandem walking test; and Fukuda step test (50 steps). Five specific clinical tests will also be carried out: Sit-to-stand-with-walk-and-turn; Perception of active body rotation; Perception of walking distance; Triangle Completion Task; and Gait assessment.

ControlsIBV patients

Four cognitive tests from the French Focus Group on Executive Functions Assessment (GREFEX) battery will be carried out: the Stroop test; the Trail Making Test; the Baddeley's dual task; and a test of Corsi's Blocks.

IBV patients

This test, also known as the unilateral centrifugation test, provides a quantitative assessment of unilateral utricular otolith function, whereas the tests currently used (vestibular evoked myogenic potential, VEMP) only provide a qualitative assessment.

ControlsIBV patients

To assess the participants' bone mineral density, the reference technique of densitometry using two-photon absorptiometry will be used.

IBV patients

Participants' ability to maintain their balance will be assessed using measurements taken on the Synapsys platform. To standardise their position, they will have to stand on the platform with their feet apart, arms at their sides and look straight ahead. Volunteers will be asked to sit down between each trial. The surface area and length of the centre of pressure will be measured under open-eye balance conditions with and without image reading/exploration and dynamics. During this test, 9 balance assessment situations lasting approximately 1 minute each will be performed.

ControlsIBV patients

Participants will be seated on a rotating chair in the dark. Using a virtual reality headset, three visual stimuli will be presented: (A) no visual stimulus (darkness), (B) visual stimulus corresponding to a displacement of the participant along a cylindrical trajectory, (C) visual stimulus corresponding to a displacement of the participant along a conical trajectory. These 3 types of visual stimuli will be presented alone or during an Off-Vertical Axis Rotation (OVAR) with the chair axis inclined at an angle of 10° to the vertical and a rotation speed of 60°/s. During each sequence, blood pressure, heart rate and end-tidal carbon dioxide (CO2) will be continuously recorded using standard medical equipment.

IBV patients

Participants will have to complete five standardised clinical questionnaires: Pittsburgh Sleep Quality Index; Spiegel questionnaire assessing sleep quality; Morningness-Eveningness questionnaire; Insomnia Severity Scale; and Epworth Sleepiness Scale. Moreover, the activity/rest rhythm will be measured continuously by actimetry over a period of 11 days. The volunteer will also have to wear a Somno-Art® bracelet all night long during the eleven days of monitoring to collect the volunteer's actimetry and heart rate in order to specify which sleep stage the volunteer is in and thus monitor changes in sleep stages over the course of the night. Finally, participants will have to complete a sleep diary.

IBV patients

* Classic geometric illusions (inverted T, Mueller-Lyer, Ponzo, Poggendorff, Zoellner, Hering) which generate systematic distortions will be used. * Time perception task: Participants will wear a virtual reality headset in which instructions will appear for 6 consecutive tasks each repeated 10 times with different durations. * Perception of rotation amplitude and duration: Participants will be seated on a rotating chair, in complete darkness with noise-cancelling headphones. Participant will have to estimate the duration and the amplitude of rotations of the chair. * Perceptual time constant: Participants will be seated on a rotating chair, in complete darkness, with a mask over their eyes and noise-cancelling headphones. After each chair rotation, participants will have to turn a crank every time the chair stops and reproduce their sensation of rotation in terms of direction (left or right) and intensity.

ControlsIBV patients

Participants will wear a virtual reality headset which allows them to be immersed in a virtual room similar in appearance to the one they are in. They will sit on a stool and hold a joystick in their hand. An avatar seen from behind, also sitting on a stool, will be presented in the centre of the virtual room approximately 2 m from them. The experimenter will touch several areas of the participant's back, over his clothes, with the end of the joystick. This movement will be reproduced by the virtual joystick in contact with the avatar's back, in two conditions: the synchronous condition, and the asynchronous condition. After 2 min of stimulation, participants will perform a mental imagery task: a ball in the background of the virtual scene will roll towards them. After 3'', a black screen will appear and participants will have to imagine that the ball keeps moving towards them at the same speed. They will have to press the trigger when they think the ball has reached their level.

IBV patients

The imaging evaluation will include an acquisition of anatomical images of the brain in its entirety and centred on the hippocampus.; and T2\*-weighted images sensitive to the blood-oxygen-level-dependent (BOLD) effect to assess functional brain activation during cognitive tasks and functional brain connectivity during rest. For the functional activation sequences, three activation tasks will be performed, each lasting approximately 5 minutes: a mental rotation task, a time estimation task, and a prediction task. These acquisitions will be combined with a collection of cardiorespiratory variables: respiratory movements and plethysmography. These signals will be used in the pre-processing of the functional MRI to remove physiological noise from the BOLD signal.

ControlsIBV patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants in the patient group are member of the French Association of the Idiopathic Bilateral Vestibulopathy (AFVBI) or carry a bilateral vestibulopathy

You may qualify if:

  • Person over 18 years of age (male or female)
  • Healthy volunteer (for participants in the control group) or a member of the French Association of the Idiopathic Bilateral Vestibulopathy (AFVBI) or a bilateral vestibulopathy carrier (for participants in the patient group).
  • Person who has read the information sheet and given written informed consent to take part in the study.
  • Person affiliated to a social security scheme

You may not qualify if:

  • Declaration of illiteracy
  • Declaration of dementia (Alzheimer's disease, vascular dementia)
  • Any progressive neurological disease (brain tumour, epilepsy, migraine, stroke, sclerosis, myoclonus, chorea, neuropathy, muscular dystrophy, myotonic dystrophy, etc.)
  • All progressive psychiatric conditions (psychosis, mood or anxiety disorders, etc.),
  • Declaration of pathologies threatening short-term vital prognosis (cancer)
  • Drug addiction, alcohol dependence or coffee abuse during the last 6 months
  • Contraindications to MRI (in particular electronic or metallic implants, claustrophobia, etc.).
  • For healthy volunteers: vestibular or auditory disorders.
  • In addition, the vulnerable persons referred to in articles L. 1121-5 to 8 and L. 1122-1-2 of the French Public Health Code are excluded from the study:
  • Pregnant, breast-feeding or parturient women,
  • Persons deprived of their liberty, hospitalised without consent or admitted to a health or social establishment for purposes other than research,
  • Minors,
  • Adults under legal protection or unable to express their consent,
  • Persons in emergency situations who are unable to give their prior consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMRs 1075 COMETE Unicaen INSERM

Caen, Calvados, 14000, France

Location

MeSH Terms

Interventions

Neuropsychological TestsCytidine Diphosphate

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and ActivitiesCytosine NucleotidesPyrimidine NucleotidesPyrimidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsNucleotidesNucleic Acids, Nucleotides, and NucleosidesRibonucleotides

Study Officials

  • Pierre DENISE, MD-PhD

    UMRs 1075 COMETE Unicaen / INSERM

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2024

First Posted

June 26, 2024

Study Start

October 5, 2022

Primary Completion

December 15, 2023

Study Completion

December 31, 2024

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations